OncoDetect - system for early detection of cancer markers in peripheral blood of patients
Public support
Provider
Technology Agency of the Czech Republic
Programme
Programme of applied research and experimental development ALFA
Call for proposals
ALFA 2 (STA02012TA02)
Main participants
Genomac výzkumný ústav, s.r.o.
Contest type
VS - Public tender
Contract ID
2012TA02010672
Alternative language
Project name in Czech
OnkoDetect - systém pro časný záchyt nádorových markerů v periferní krvi pacientů
Annotation in Czech
Vývoj prototypu přístroje pro záchyt nádorově-specifických DNA a RNA markerů v periferní krvi onkologických pacientů. Přístroj je založen na kombinaci mikrofluidního reaktoru a separátoru umožňujícího zpracování a analýzu předupraveného vzorku krevní plasmy. Bude využito unikátní kombinace elektromigračních transportů a interakce nanočástic (tzv. kvantových teček) s fragmenty DNA/RNA. Výsledkem projektu bude funkční prototyp, užitný vzor a patentová příhláška.
Scientific branches
R&D category
AP - Applied research
CEP classification - main branch
EI - Biotechnology and bionics
CEP - secondary branch
EB - Genetics and molecular biology
CEP - another secondary branch
CB - Analytical chemistry, separation
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
10406 - Analytical chemistry<br>10603 - Genetics and heredity (medical genetics to be 3)<br>10604 - Reproductive biology (medical aspects to be 3)<br>10605 - Developmental biology<br>10608 - Biochemistry and molecular biology<br>10609 - Biochemical research methods<br>20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>30101 - Human genetics<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics
Completed project evaluation
Provider evaluation
U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)
Project results evaluation
The Opposition Commitee notes that at the date of the Final Opponent Meeting the project succeeded according to the assignment, as the project objectives and declared results were achieved.
Solution timeline
Realization period - beginning
Jan 1, 2012
Realization period - end
Dec 31, 2016
Project status
U - Finished project
Latest support payment
Feb 18, 2016
Data delivery to CEP
Confidentiality
C - Předmět řešení projektu podléhá obchodnímu tajemství (§ 504 Občanského zákoníku), ale název projektu, cíle projektu a u ukončeného nebo zastaveného projektu zhodnocení výsledku řešení projektu (údaje P03, P04, P15, P19, P29, PN8) dodané do CEP, jsou upraveny tak, aby byly zveřejnitelné.
Data delivery code
CEP17-TA0-TA-U/01:1
Data delivery date
Jun 30, 2017
Finance
Total approved costs
19,486 thou. CZK
Public financial support
11,965 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
7,521 thou. CZK